These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9161644)

  • 1. Reliability of drug utilization evaluation as an assessment of medication appropriateness.
    Shelton PS; Hanlon JT; Landsman PB; Scott MA; Lewis IK; Schmader KE; Samsa GP; Weinberger M
    Ann Pharmacother; 1997 May; 31(5):533-42. PubMed ID: 9161644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of a modified medication appropriateness index in ambulatory older persons.
    Fitzgerald LS; Hanlon JT; Shelton PS; Landsman PB; Schmader KE; Pulliam CC; Williams ME
    Ann Pharmacother; 1997 May; 31(5):543-8. PubMed ID: 9161645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of a modified medication appropriateness index in primary care.
    Bregnhøj L; Thirstrup S; Kristensen MB; Sonne J
    Eur J Clin Pharmacol; 2005 Nov; 61(10):769-73. PubMed ID: 16200422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of STOPP and START criteria: interrater reliability among pharmacists.
    Ryan C; O'Mahony D; Byrne S
    Ann Pharmacother; 2009 Jul; 43(7):1239-44. PubMed ID: 19584381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of a modified medication appropriateness index in community pharmacies.
    Kassam R; Martin LG; Farris KB
    Ann Pharmacother; 2003 Jan; 37(1):40-6. PubMed ID: 12503931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of the medication appropriateness index in Dutch residential home.
    Stuijt CC; Franssen EJ; Egberts AC; Hudson SA
    Pharm World Sci; 2009 Jun; 31(3):380-6. PubMed ID: 19280363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter- and intrarater reliability of retrospective drug utilization reviewers.
    Zuckerman IH; Mulhearn DM; Metge CJ
    J Am Pharm Assoc (Wash); 1999; 39(1):45-9. PubMed ID: 9990187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.
    Schneeweiss S; Soumerai SB; Glynn RJ; Maclure M; Dormuth C; Walker AM
    CMAJ; 2002 Mar; 166(6):737-45. PubMed ID: 11944760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized drug-use evaluation.
    O'Connell HM; Chance S; Bowman L
    Am J Hosp Pharm; 1994 Feb; 51(3):363-7. PubMed ID: 8160689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the appropriateness and safety of nurse and midwife prescribing in Ireland.
    Naughton C; Drennan J; Hyde A; Allen D; O'Boyle K; Felle P; Butler M
    J Adv Nurs; 2013 Jul; 69(7):1478-88. PubMed ID: 22989189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication appropriateness index: reliability and recommendations for future use.
    Spinewine A; Dumont C; Mallet L; Swine C
    J Am Geriatr Soc; 2006 Apr; 54(4):720-2. PubMed ID: 16686895
    [No Abstract]   [Full Text] [Related]  

  • 12. A comprehensive appropriateness of prescribing questionnaire was validated by nominal consensus group.
    Holbrook AM; Janjusevic V; Goldsmith CH; Shcherbatykh IY;
    J Clin Epidemiol; 2007 Oct; 60(10):1022-8. PubMed ID: 17884596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity.
    Samsa GP; Hanlon JT; Schmader KE; Weinberger M; Clipp EC; Uttech KM; Lewis IK; Landsman PB; Cohen HJ
    J Clin Epidemiol; 1994 Aug; 47(8):891-6. PubMed ID: 7730892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edmonton Quality Assessment Tool for Drug Utilization Reviews: EQUATDUR-2: the development of a scale to assess the methodological quality of a drug utilization review.
    Spooner CH; Pickard AS; Menon D
    Med Care; 2000 Sep; 38(9):948-58. PubMed ID: 10982116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the assessment of preventable adverse drug events in daily clinical practice.
    van Doormaal JE; Mol PG; van den Bemt PM; Zaal RJ; Egberts AC; Kosterink JG; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):645-54. PubMed ID: 18338767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Functional Movement Screen: a reliability study.
    Teyhen DS; Shaffer SW; Lorenson CL; Halfpap JP; Donofry DF; Walker MJ; Dugan JL; Childs JD
    J Orthop Sports Phys Ther; 2012 Jun; 42(6):530-40. PubMed ID: 22585621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new tool for identifying discrepancies in postacute medications for community-dwelling older adults.
    Smith JD; Coleman EA; Min SJ
    Am J Geriatr Pharmacother; 2004 Jun; 2(2):141-7. PubMed ID: 15555490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the value, accuracy, and operational feasibility of DUE criteria.
    Ben-Joseph R; Segal R; Russell WL; Oh T
    Formulary; 1995 May; 30(5):280-3. PubMed ID: 10151727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.